Cargando…
Risk Factors for Candidemia as Compared with Patients with Negative Blood Cultures Placed on Empiric Micafungin
BACKGROUND: Numerous risk factors have been linked to invasive candidiasis; however, they are nonspecific and often trigger empiric antifungal therapy in a large number of patients. Identification of more precise predictors could promote judicious use of empiric echinocandins. Ultimately, this could...
Autores principales: | Carr, Amy, Berhe, Mezgebe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631960/ http://dx.doi.org/10.1093/ofid/ofx163.021 |
Ejemplares similares
-
Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients
por: Suh, Jin Woong, et al.
Publicado: (2020) -
2111. Anidulafungin vs. Micafungin Treatment in Adult Patients with Candidemia: A Retrospective Study of Single-Center Experience
por: Suh, Jinwoong, et al.
Publicado: (2019) -
Validation of an Empiric Candidemia Treatment Algorithm
por: Stack, Conor M, et al.
Publicado: (2017) -
2442. Outcomes in ESBL Bacteremia Empirically Treated With Piperacillin/Tazobactam or Carbapenems
por: John, Reeba, et al.
Publicado: (2018) -
258. False Negative Rate of T2Candida Assay in Blood Culture Positive Candidemia
por: McCarty, Todd, et al.
Publicado: (2019)